Cargando…
Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer
Primary prostate tumor heterogeneity is poorly understood, leaving research efforts with challenges regarding the initiation and advancement of the disease. The growth of tumor cells is accompanied by mutations in nuclear and in mitochondrial genomes. Thus, mitochondrial DNA mutations may be used as...
Autores principales: | Arstad, Christian, Taskén, Kristin, Refinetti, Paulo, Axcrona, Ulrika, Giercksky, Karl-Erik, Ekstrøm, Per Olaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474793/ https://www.ncbi.nlm.nih.gov/pubmed/32908706 http://dx.doi.org/10.1155/2020/7673684 |
Ejemplares similares
-
Is detection of intraperitoneal exfoliated tumor cells after surgical resection of rectal cancer a prognostic factor of survival?
por: Arstad, Christian, et al.
Publicado: (2017) -
Mapping mitochondrial heteroplasmy in a Leydig tumor by laser capture micro-dissection and cycling temperature capillary electrophoresis
por: Refinetti, Paulo, et al.
Publicado: (2017) -
Tracing of Human Tumor Cell Lineages by Mitochondrial Mutations
por: Refinetti, Paulo, et al.
Publicado: (2020) -
Quantifying mitochondrial DNA copy number using robust regression to interpret real time PCR results
por: Refinetti, Paulo, et al.
Publicado: (2017) -
Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
por: Ma, Yuanyuan, et al.
Publicado: (2012)